Shore Capital Reaffirms Buy Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Shore Capital in a note issued to investors on Tuesday, MarketBeat reports. Several other equities analysts have also issued reports on the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 140 ($1.87) price target on shares […]
AstraZeneca (LON:AZN – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Shore Capital in a note issued to investors on Tuesday, MarketBeat reports. Several other equities analysts have also issued reports on the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 140 ($1.87) price target on shares […]
